Jewel-Osco celebrates Hispanic Heritage Month with ‘Sabor de la Herencia Hispana’
ITASCA, Ill. A Midwest food and drug retailer is celebrating Hispanic Heritage Month with its third annual VIP reception to honor the culture and significant achievements of the Hispanic community.
Jewel-Osco is holding its signature event, “Sabor de la Herencia Hispana” (Taste of Hispanic Heritage), on Sept. 22, and is dedicated to recognizing the continuous efforts and outstanding contributions made by leaders from the civic, business and nonprofit sectors of the community. During the VIP reception, Jewel-Osco will honor three social service agencies for their efforts and their commitment to enriching the Hispanic communities they serve. This year, Jewel-Osco will award a total of $15,000 in grants to Association House, Namaste Charter School and The Resurrection Project. The work of these organizations reflects Jewel-Osco’s pledge to support initiatives that mirror the company’s charitable giving strategy, which focuses on three areas: hunger relief, nutrition education and environmental stewardship, the retailer said.
The event also will highlight the unique flavors and richness of Latin cuisine, by showcasing exclusive dishes developed by culinary students from Chicago’s St. Augustine College.
“We are proud to observe Hispanic Heritage Month with an event that celebrates the culture and traditions of the Latino community,” said Jewel-Osco president, Keith Nielsen. “‘Sabor de la Herencia Hispana’ supports the culinary talent of Hispanic youth and recognizes the exceptional contributions of this community.”
GSK, Genmab begin late-stage clinical trial for cancer drug
NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial of a biotech drug for treating cancer, the two companies said.
GSK and Genmab announced Wednesday that they had started a phase-3 trial of the drug ofatumumab in patients with non-Hodgkin’s lymphoma with the aim of extending survival without progression of the disease in patients did not respond to therapy with Rituxan (rituximab), a drug made by Genentech and Biogen Idec. The 338 patients in the trial have indolent B-cell NHL, which accounts for more than one-third of lymphoma cases.
Patients will randomly receive a combination of ofatumumab and Cephalon’s Treanda (bendamustine hydrochloride), or Treanda alone. Patients receiving Treanda alone will have the opportunity to receive ofatumumab if their disease progresses.
As part of an agreement between the two companies, Genmab will receive a milestone payment of $20 million.
Live from your living room, it’s Saturday night
SEATTLE Discovery Bay Games and Broadway Video Enterprises are bringing sketch comedy series "Saturday Night Live" into living rooms nationwide with the launch of a new board game.
Currently available at such retailers as Walmart and Kmart, Saturday Night Live – The Game features a mix of "SNL"-inspired activities that will get players acting, improvising, guessing and laughing out loud. Players customize each game by choosing cards from the "SNL" eras they know best (1970s, 1980s, 1990s and 2000s). "Saturday Night Live," which debuted in October 1975, is the most Emmy-nominated show in TV history with 126 nominations, and has been honored twice with the prestigious George Foster Peabody Award. The show has launched the careers of many of the brightest comedic talents of their respective generations.
“We are really happy with what Discovery Bay Games created,” said Britta von Schoeler, SVP and general manager for Broadway Video Enterprises. “The game stays true to the show’s history and allows people to bring its energy into their homes.”